Other Local Peers |
EXACT SCIENCES CORP (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), BIO-TECHNE CORP (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INSMED INC (NASDAQ), ARVINAS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), VERACYTE INC (NASDAQ), ALKERMES PLC (NASDAQ), NANTKWEST INC (NASDAQ), VIELA BIO INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), SEER INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), ALLOVIR INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), PRECIGEN INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), REGENXBIO INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), OCUGEN INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), BIOATLA INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), MACROGENICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), NKARTA INC (NASDAQ), CYTOKINETICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALECTOR INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), VAXCYTE INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OMEROS CORP (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PASSAGE BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), INHIBRX INC (NASDAQ), EPIZYME INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MERUS B V (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CHIMERIX INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), KADMON HLDGS INC (NASDAQ), HUMANIGEN INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), COMPUGEN (NASDAQ), ATRECA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AFFIMED N V (NASDAQ), AGENUS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ARDELYX INC (NASDAQ), AKOUOS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), XBIOTECH INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), IVERIC BIO INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), ALTIMMUNE INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVROBIO INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ADICET BIO INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), SESEN BIO INC (NASDAQ), VERASTEM INC (NASDAQ), ATHERSYS INC (NASDAQ), ONCORUS INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), IMMUNOME INC (NASDAQ), NEXTCURE INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), KAMADA LTD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), MEDICINOVA INC (NASDAQ), CABALETTA BIO INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), METACRINE INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), IMV INC (NASDAQ), INMUNE BIO INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), BIOVIE INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CHIASMA INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ORGENESIS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), EVOGENE LTD (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), CONTRAFECT CORP (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), LONGEVERON INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ARAVIVE INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), SYNLOGIC INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), INFLARX N V (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), SAVARA INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), COHBAR INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ADVAXIS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BIOCARDIA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), SOLIGENIX INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), PRECIPIO INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), HISTOGEN INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ) |
Other Global Peers |
ARCUS BIOSCIENCES INC (NYSE), NUVATION BIO INC (NYSE), MYOVANT SCIENCES LTD (NYSE), JACOBIO-B (HKEx), VIVA BIOTECH (HKEx), JW THERAP-B (HKEx), ALPHAMAB-B (HKEx), FRONTAGE (HKEx), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), JHBP-B (HKEx), MESOBLAST LTD (ASX), KINTOR PHARMA-B (HKEx), TELIX PHARMACEUTIC (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), SINOMAB BIO-B (HKEx), DPHARMA (Bursa), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), OPTHEA LIMITED (ASX), SQZ BIOTECHNOLOGIES CO (NYSE), IMUGENE LIMITED (ASX), NANOVIRICIDES INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), ANTEOTECH LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), BIONOMICS LTD (ASX), NEXT SCIENCE LTD (ASX), CEL-SCI CORP (NYSE American), BIOMX INC (NYSE American), IMMUTEP LTD (ASX), ENZO BIOCHEM INC (NYSE), IBIO INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), NEUREN PHARMACEUTICALS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), UNI-BIO GROUP (HKEx), AIM IMMUNOTECH INC (NYSE American), LEAF RESOURCES LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), REGENT PACIFIC (HKEx), GENETIC TECHNOLOGIES (ASX), MEMPHASYS LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), CT ENTERPRISE (HKEx), ORAGENICS INC (NYSE American), BIOTRON (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), PATRYS LIMITED (ASX), Suntar Eco-City (SGX), BIOSINO BIO-TEC (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), REGENEUS LTD (ASX), RHINOMED LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ANATARA LIFESCIENCES LTD (ASX), NANOLLOSE LTD (ASX), HAO WEN HLDGS (HKEx), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), FACTOR THERAPEUTICS LIMITED (ASX) |